A vector-based short hairpin RNA targeting Aurora A inhibits breast cancer growth

International Journal of Oncology

Volumn 36, Issue 5, 2010, Pages 1121-1128

  Wan, Yang ^a   Huang, Anliang ^a   Yang, Yang ^a   Xie, Gang ^a   Chen, Xiang ^a   Hu, Jia ^a   Chen, Xiancheng ^a   Yang, Li ^a   Li, Jiong ^a   Chen, Lijuan ^a   Jiang, Yu ^a   Zhao, Xia ^b   Wei, Yuquan ^a   Deng, Hongxin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Aurora A; Breast cancer; Short hairpin RNA

Indexed keywords

AURORA A KINASE; PGENESIL 2 HK PLASMID VECTOR; PGENESIL 2 PLASMID VECTOR; PGENESIL 2 SHAURKA PLASMID VECTOR; PLASMID VECTOR; PROPIDIUM IODIDE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CENTROSOME; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CATIONS; CELL LINE, TUMOR; DNA; FEMALE; FLOW CYTOMETRY; GENETIC TECHNIQUES; GENETIC VECTORS; HUMANS; KI-67 ANTIGEN; LIPOSOMES; NEOPLASM TRANSPLANTATION; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77950379349     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000594     Document Type: Article

References (43)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Porter P: 'Westernizing' women's risks? Breast cancer in lower-income countries. N Engl J Med 358: 213-216, 2008.
3. Joanne L: Breast cancer in 2007 incidence risk assessment and risk reduction strategies. Clin J Oncol Nurs 11: 619-622, 2007.
4. De Laurentiis M, Cancello G, D'Agostino D, et al: Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. J Clin Oncol 26: 44-53, 2008.
5. Sparano JA, Wang M, Martino S, et al: Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358: 1663-1671, 2008.
6. Warner SL, Bearss DJ, Han H and Von Hoff DD: Targeting Aurora-2 kinase in cancer. Mol Cancer Ther 2: 589-595, 2003.
7. Kimura M, Kotani S, Hattori T, et al: Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosphila and yeast Ipl1. J Biol Chem 272: 13766-13771, 1997.
8. Berdnik D and Knoblich JA: Drosophila Aurora-A is required for centrosome maturation and actin-dependent asymmetric protein localization during mitosis. Curr Biol 12: 640-647, 2002.
9. Giet R, McLean D, Descamps S, Lee MJ, Raff JW, Prigent C and Glover DM: Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J Cell Biol 156: 437-451, 2002.
10. Hannak E, Kirkham M, Hyman AA and Oegema K: Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans. J Cell Biol 155: 1109-1116, 2001.
11. Bischoff JR, Anderson L, Zhu Y, et al: A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17: 3052-3065, 1998.
12. Montembault E and Prigent C: Aurora kinases: therapeutic potential. Drugs Future 30: 29, 2005.
13. Nadler Y, Camp RL, Schwartz C, Rimm DL, Kluger HM and Kluger Y: Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer. Clin Cancer Res 14: 4455-4462, 2008.
14. Mario Stevenson: Therapeutic potential of RNA interference. N Engl J Med 351: 1772-1777, 2004.
15. Boudreau RL and Davidson BL: RNAi therapy for neuro-degenerative diseases (Review). Curr Top Dev Biol 75: 73-92, 2006.
16. Campochiaro PA: Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders. Gene Ther 13: 559-562, 2006.
17. Lee NS, Dohjima T, Bauer G, et al: Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20, 500-505, 2002.
18. Hata T, Furukawa T, Sunamura M, et al: RNA interference targeting Aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 65: 2899-2905, 2005.
19. Yuan Z, Liu H, Yan F, et al: Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene. Cancer Sci 100: 1757-1766, 2009.
20. Marumoto T, Zhang D and Saya H: Aurora-A - a guardian of poles. Nat Rev Cancer 5: 42-50, 2005.
21. Fu J, Bian M, Jiang Q and Zhang C: Roles of aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 5: 1-10, 2007.
22. Hirota T, Kunitoku N, Sasayama T, et al: Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 114: 585-598, 2003.
23. Kufer TA, Silljé HH, Körner R, Gruss OJ, Meraldi P and Nigg EA: Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 158: 617-623, 2002.
24. Katayama H, Sasai K, Kloc M, Brinkley BR and Sen S: Aurora kinase-A regulates kinetochore/chromatin associated microtubule assembly in human cells. Cell Cycle 7: 2691-2704, 2008.
25. Wang X, Zhou YX, Qiao W, Tominaga Y, Ouchi M, Ouchi T and Deng CX: Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25: 7148-7158, 2006.
26. Lee HH, Zhu Y, Govindasamy KM and Gopalan G: Down-regulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells. Endocr Relat Cancer 15: 765-775, 2008.
27. Agnese V, Bazan V, Fiorentino FP, et al: The role of Aurora-A inhibitors in cancer therapy. Ann Oncol 18: vi47-vi52, 2007.
28. Coumar MS, Leou JS, Shukla P, et al: Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity. J Med Chem 52: 1050-1062, 2009.
29. Deng XQ, Wang HY, Zhao YL, et al: Development and biological evaluation of a novel Aurora A kinase inhibitor pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors. Chem Biol Drug Des 71: 533-539, 2008.
30. Miyagishi M and Taira K: U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20: 497-500, 2002.
31. Paul CP, Good PD, Winer I and Engelke DR: Effective expression of small interfering RNA in human cells. Nat Biotechnol 20: 505-508, 2002.
32. Leung RK and Whittaker PA: RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther 107: 222-239, 2005.
33. Miyagishi M and Taira K: Strategies for generation of an SiRNA expression library directed against the human genome. Oligonucleotides 13: 325-333, 2003.
34. Siolas D, Lerner C, Burchard J, et al: Synthetic shRNAs as potent RNAi triggers. Nat Biotechnol 23: 227-231, 2005.
35. Wu MT, Wu RH, Hung CF, Cheng TL, Tsai WH and Chang WT: Simple and efficient DNA vector-based RNAi systems in mammalian cells. Biochem Biophys Res Commun 330: 53-59, 2005.
36. Rao DD, Vorhies JS, Senzer N and Nemunaitis J: siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev 61: 746-759, 2009.
37. Tao Y, Zhang P, Frascogna V, Lecluse Y, Auperin A, Bourhis J and Deutsch E: Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. Br J Cancer 97: 1664-1672, 2007.
38. Evans R, Naber C, Steffler T, et al: Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells. Leuk Lymphoma 49: 559-569, 2008.
39. Yang H, He L, Kruk P, Nicosia SV and Cheng JQ: Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer 119: 2304-2312, 2006.
40. Wang XX, Liu R, Jin SQ, Fan FY and Zhan QM: Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Res 16: 356-366, 2006.
41. Samaras V, Stamatelli A, Samaras E, et al: Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features. Pathol Res Pract 205: 765-773, 2009.
42. Mahato RI, Anwer K, Tagliaferri F, et al: Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum Gene Ther 9: 2083-2099, 1998.
43. Zhang Y, Bradshaw-Pierce EL, Delille A, Gustafson DL and Anchordoquy TJ: In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: Effects on biodistribution and tumor accumulation. J Pharm Sci 97: 237-250, 2008.